Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sézary syndrome: old enigmas, new targets
Jan P. Nicolay, Moritz Felcht, Kai Schledzewski, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2016) Vol. 14, Iss. 3, pp. 256-264
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 39
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
Jan P. Nicolay, Karin Müller‐Decker, Anne Schroeder, et al.
Blood (2016) Vol. 128, Iss. 6, pp. 805-815
Open Access | Times Cited: 78
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR 3 DL 2 marker
Marie Roelens, Adèle de Masson, C. Ram‐Wolff, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 6, pp. 1415-1422
Closed Access | Times Cited: 30
Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
Marie Roelens, Adèle de Masson, Anaïs Andrillon, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 6, pp. 1010-1025
Closed Access | Times Cited: 18
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma
Eirini Kalliara, Emma Belfrage, Urban Gullberg, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2362-2362
Open Access | Times Cited: 10
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Tabea C. Froehlich, Karin Müller‐Decker, Jana D. Braun, et al.
Blood (2019) Vol. 134, Iss. 5, pp. 445-455
Open Access | Times Cited: 21
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Leukemia (2020) Vol. 35, Iss. 6, pp. 1696-1709
Open Access | Times Cited: 20
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine
Edith Chevret, Jean‐Philippe Merlio
Journal of Investigative Dermatology (2016) Vol. 136, Iss. 7, pp. 1319-1324
Open Access | Times Cited: 17
Aberrant microRNA expression in tumor mycosis fungoides
Evangelia Papadavid, Maria Braoudaki, Marilena M. Bourdakou, et al.
Tumor Biology (2016) Vol. 37, Iss. 11, pp. 14667-14675
Closed Access | Times Cited: 17
Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model
Justine Habault, Nicolas Thonnart, C. Ram‐Wolff, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2933-2933
Open Access | Times Cited: 8
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients
Susanne Melchers, M. Roemer, John D. Albrecht, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access | Times Cited: 1
Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells
Isabella J. Brouwer, Jacoba J. Out‐Luiting, Maarten H. Vermeer, et al.
Biochemistry and Biophysics Reports (2020) Vol. 24, pp. 100832-100832
Open Access | Times Cited: 12
NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib
Michael K. Kießling, Jan P. Nicolay, Tabea Schlör, et al.
Oncotarget (2017) Vol. 8, Iss. 28, pp. 45687-45697
Open Access | Times Cited: 12
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
Inès Vergnolle, Claudia Douat-Beyries, S. Boulinguez, et al.
Blood Advances (2021) Vol. 6, Iss. 6, pp. 1813-1825
Open Access | Times Cited: 10
Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions
Alvise Sernicola, Irene Russo, Micol Silic‐Benussi, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 3, pp. 275-282
Closed Access | Times Cited: 9
Therapie der Mycosis fungoides und des Sézary-Syndroms
Jan P. Nicolay, Chalid Assaf
Der Hautarzt (2017) Vol. 68, Iss. 9, pp. 702-710
Closed Access | Times Cited: 9
Care structure of patients with mycosis fungoides and Sézary syndrome in Germany – Care research based on SHI claims data
Chalid Assaf, Gábor Dobos, Immo‐Maximilian Zech, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 5, pp. 643-651
Open Access | Times Cited: 5
The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway
Hongyang Li, Cheng Wang, Pengcheng Ma, et al.
Journal of Dermatological Science (2020) Vol. 97, Iss. 3, pp. 208-215
Closed Access | Times Cited: 6
Types of T-cell lymphoma-a cytogenetic perspective
Muhammad Ammar Samad, Eman Mahboob, Aimen Shafiq, et al.
Annals of Medicine and Surgery (2022) Vol. 84
Open Access | Times Cited: 3
Dimethyl fumarate and extracorporeal photopheresis combination-therapy synergize in inducing specific cell death and long-term remission in cutaneous T cell lymphoma
Özge Çiçek Şener, Susanne Melchers, Luisa Tengler, et al.
Leukemia (2024)
Open Access
Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary‐Syndrom in Deutschland – Versorgungsforschung auf Basis von GKV‐Routinedaten
Chalid Assaf, Gábor Dobos, Immo‐Maximilian Zech, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 5, pp. 643-652
Open Access | Times Cited: 2
Micellar Curcumin Substantially Increases the Antineoplastic Activity of the Alkylphosphocholine Erufosine against TWIST1 Positive Cutaneous T Cell Lymphoma Cell Lines
Antonios Trochopoulos, Yana Ilieva, Alexander Dimitrov Kroumov, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2688-2688
Open Access | Times Cited: 2
Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems
Л Р Тилова, Alena V. Savinkova, Ekaterina M. Zhidkova, et al.
Clinical oncohematology (2017) Vol. 10, Iss. 2, pp. 235-249
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top